The recent study found the addition of microbiome analysis helped identify high-risk patients, who should undergo colonoscopy screening. The study’s authors concluded that microbiome analysis should be used in conjunction with FOBT, rather than as a replacement.
More articles on gastroenterology:
Financial leadership playbook: The essential skills for a CFO in gastroenterology
Higher Medicaid reimbursement associated with higher cancer screening rates
The biggest threats to success in the GI field
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
